Search
Ioxitalamic acid
go.drugbank.com/drugs/DB13444ApprovedWithdrawnIoxitalamate is an ionic iodinated contrast medium. It is a first-generation contrast media formed by an ionic monomer with a high osmolarity of 1500-1800 mOsm/kg. Ioxitalamic acid in the salt forms of sodium and meglumine was developed ...
Categories: Compounds used in a research, industrial, or household settingAmiloxate
go.drugbank.com/drugs/DB11207ApprovedIt is often referred to as isoamyl 4-methoxycinnamate or isoamyl p-methoxycinnamate. Amiloxate is a cinnamic acid derivative with an anti-inflammatory activity [A32916].
JNJ-64400141
go.drugbank.com/drugs/DB24373InvestigationalJNJ-64400141 is under investigation in clinical trial NCT05242432 (A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory
Masitinib
go.drugbank.com/drugs/DB11526InvestigationalVet approvedIn the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
Utatrectinib
go.drugbank.com/drugs/DB21295InvestigationalUtatrectinib is under investigation in clinical trial NCT01468324 (AZD7451 for Recurrent Gliomas). Utatrectinib has a monoisotopic molecular weight of 382.17 Da.
Beta-(1,3)-D glucan
go.drugbank.com/drugs/DB16468InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Valethamate
go.drugbank.com/drugs/DB13497InvestigationalCategories: Drugs for Functional Gastrointestinal DisordersSOR-C13
go.drugbank.com/drugs/DB15366InvestigationalSOR-C13 is under investigation in clinical trial NCT01578564 (Safety and Tolerability Study of SOR-C13 in Subjects With Advanced Cancers Commonly Known to Express the TRPV6 Channel).
Penimepicycline
go.drugbank.com/drugs/DB13264ExperimentalPenimepicycline is a tetracycline-class antibiotic. It is mentioned on List A produced by the Government of Canada, which is a list of antimicrobial active pharmaceutical ingredients . In the classification of the active ingredients incl...
Categories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCRx-139
go.drugbank.com/drugs/DB05744ExperimentalThis novel synergistic combination is developed for the treatment of immuno-inflammatory diseases.